Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

Which of the following is NOT typically considered a patient-specific factor when selecting initial antihypertensive therapy for adults?

Choosing initial antihypertensive therapy is guided by factors that change the expected benefits and risks of drugs for a specific patient. Age influences how patients respond to certain medications and what’s well tolerated. Comorbid conditions like diabetes or CKD steer drug choice toward agents with favorable renal and metabolic effects—ACE inhibitors or ARBs are often preferred because of kidney protection and metabolic considerations. Pregnancy status drastically alters safety; many antihypertensives are contraindicated in pregnancy, so the regimen must be chosen with pregnancy in mind. Dietary salt intake, while it affects blood pressure and is important to address through lifestyle modification, does not determine which antihypertensive drug should be started. It’s a modifiable factor applicable across patients, not a characteristic that changes drug selection. Hence, it’s not typically used to choose the initial therapy.

Choosing initial antihypertensive therapy is guided by factors that change the expected benefits and risks of drugs for a specific patient. Age influences how patients respond to certain medications and what’s well tolerated. Comorbid conditions like diabetes or CKD steer drug choice toward agents with favorable renal and metabolic effects—ACE inhibitors or ARBs are often preferred because of kidney protection and metabolic considerations. Pregnancy status drastically alters safety; many antihypertensives are contraindicated in pregnancy, so the regimen must be chosen with pregnancy in mind.

Dietary salt intake, while it affects blood pressure and is important to address through lifestyle modification, does not determine which antihypertensive drug should be started. It’s a modifiable factor applicable across patients, not a characteristic that changes drug selection. Hence, it’s not typically used to choose the initial therapy.